_:nf1e96c4896074e16a0f0f8d6917318ecxb0
<http://schema.org/name>
"Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy "
<https://www.mysciencework.com/publication/facets/journal/Familial%2520Cancer>